Purine metabolism (salvage)

The purine nucleotides are not only required as components of nucleic acids, but also as cofactors of metabolic processes and as a source of energy (ATP). Apicomplexa cannot synthesise purine rings de novo and salvage them from host. The putative transporters involved in the uptake of purine bases and nucleosides from parasitophorous vacuole are present in all apicomplexans including Toxoplasma gondii, Plasmodium falciparum and Cryptosporidium parvum. There were four transporters identified in T. gondii of which three are present in the genome of ME49 strain, whereas all four are present in VEG and GT1 strain genomes. In contrast, a single purine nucleotide transporter is present in Cryptosporidium species. It was identified as an ortholog of the adenosine transporter in C. parvum [1]. Cryptosporidium species possess limited set of enzymes involved in the salvage and inter-conversion of purines. Although an early study suggested the expression of hypoxanthine-xanthine-guanine phosphoribosyltransferase (HXGPRT) and adenine phosphoribosyltransferase (APRT) [2], both these enzymes are absent in all Cryptosporidium genomes sequenced. In addition, the treatment of C. parvum with 6-thioxanthine had no effect strongly suggesting the absence of HXGPRT [3]. All these suggest that adenosine is the only source of purine in Cryptosporidia. Adenosine kinase (AK) is present in the genomes of Cryptosporidia species. The transgenic expression of putative C. parvum adenosine kinase gene complements the enzymatic activity in the T. gondii AK null mutant [3]. The downstream enzymes involved in the inter-conversion of AMP to GMP (IMP dehydrogenase and GMP synthase) are also present in Cryptosporidium parvum and Cryptosporidium hominis. The sensitivity and inhibition of development of C. parvum to IMP dehydrogenase inhibitors such as mycophenolic acid and ribavrin confirms the presence of this enzymatic activity. Unlike mammalian cells and T. gondii, IMP dehydrogenase is a potential drug target in C. parvum as this is the only route of guanine nucleotide synthesis[3].


Enzyme EC Number Gene id
IMP dehydrogenase Chro.60012
Ribonucleotide di-P reductase Chro.60090
Ribonucleotide reductase Chro.60230
TRX reductase Chro.20464
Adenosine kinase Missing in annotation
Adenylate kinase Chro.30373
Adenylate kinase Chro.50037
Nucleoside-diphosphate kinase Chro.40219
Nucleoside-diphosphate kinase Chro.50237
Guanylate kinase Chro.70250
5'-nucleotidase Chro.50026
3',5'-cyclic-nucleotide phosphodiesterase Chro.30269
3',5'-cyclic-nucleotide phosphodiesterase Chro.60068
3',5'-cyclic-nucleotide phosphodiesterase Chro.60462
AMP deaminase Chro.40214
Inorganic diphosphatase Chro.40159
Ecto-nucleoside triphosphate diphosphohydrolase Missing in annotation
Nucleoside-triphosphate pyrophosphatase Chro.40472
Apyrase Chro.60194
Adenylate cyclase Chro.20139
Adenylate cyclase Chro.40352
Guanylate cyclase Chro.30141
GMP synthase Chro.50499
Equilibrative nucleoside (adenosine) transporter none Chro.20039


Open in a new window



Sources and fates of metabolites


Substrate Source pathways Product Fate pathways
Adenosine Host dATP/dGTP DNA replication
    ATP/GTP Transcription, Many metabolic pathways
Glutamine Glutamate metabolism Glutamate Glutamate metabolism

Nucleoside catabolism


Open in a new window